<DOC>
	<DOCNO>NCT02935699</DOCNO>
	<brief_summary>This multicenter , parallel group , randomize , double-blind , active control , Phase III clinical study cetirizine injection , 10 mg/mL , compare diphenhydramine injection , 50 mg/mL ( Benadryl generic equivalent ) , approximately 256 patient ( 1:1 ratio ) acute urticaria require treatment Emergency Departments , hospital , Urgent Care Centers , Allergy Clinics , etc .</brief_summary>
	<brief_title>Clinical Trial Comparing JDP-205 Diphenhydramine Injection Treatment Acute Urticaria</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>1 . Male female patient diagnosis acute urticaria need treatment antihistamine alleviate symptom ; 2 . 18 year age old ; 3 . Be willing able give inform consent ; 4 . Patients Patient rat Pruritus Severity Score â‰¥ 1 1 . Receipt investigational drug device , within past 30 day ; 2 . Patients antihistamine may contraindicate ( e.g . narrow angle glaucoma , symptomatic prostatic hypertrophy ) ; 3 . Patients , opinion investigator , may tolerate IV injection diphenhydramine 50 mg , cetirizine 10 mg ; 4 . Receipt antihistamine ( H1 antagonist ) within past 2 hour regardless route administration , e.g . diphenhydramine , cetirizine , loratadine , fexofenadine , levocetirizine , desloratadine ; 5 . Receipt H2 antagonist within past 2 hour ; 6 . Receipt doxepin within past 2 hour ; doxepin antidepressant , also antihistamine property ; 7 . Receipt steroids oral , IV , IM , inhalational route route within past 4 hour manage acute allergic reaction ; 8 . Receipt epinephrine ( EpiPen brand ) within past 20 minute ; 9 . Anaphylaxis prior acute anaphylactic symptom treat . 10 . Has know allergy hydroxyzine , cetirizine levocetirizine , diphenhydramine ; 11 . Pregnancy breastfeeding ; 12 . Patients acute allergic reaction medication take ( e.g . antibiotic , NSAIDs , etc . ) stop medication ; 13 . Patients , base medical history opinion investigator , chronic urticaria , hereditary angioedema , urticaria refractory antihistamine , dermatological disease interfere evaluation therapeutic response ; 14 . Any condition view investigator make subject unsuitable enrollment study ; 15 . History HIV known immunodeficiency ; 16 . Major medical psychiatric illness , acute urticaria , time presentation ; 17 . Inability provide inform consent . 18 . Patients concomitant pglycoprotein inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>